EUVIMEDEUVIMED entdecken
LeserbriefBeobachtungsstudie

Observational study with lenvatinib and pembrolizumab in heavily pretreated patients with metastatic melanoma

Marek Pásek iD, Emanuel Marques iD, Jiří Švec iD, Petr Arenberger iD, Monika Arenbergerová iD

International Journal of Dermatology · 2024

DOI: 10.1111/ijd.17285 ↗

Kurz gefasst

Leserbrief in der Zeitschrift International Journal of Dermatology, 2024. Verfasst von Marek Pásek und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Third Faculty of Medicine, Charles University, and Královské Vinohrady University Hospital, Prague, Czech …. Hauptthemen laut MEDLINE: Melanoma, Antibodies, Monoclonal, Humanized, Phenylurea Compounds, Quinolines. Die Arbeit nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaAntibodies, Monoclonal, HumanizedPhenylurea CompoundsQuinolinesSkin NeoplasmsHumansMaleFemaleMiddle AgedAgedAntineoplastic Combined Chemotherapy ProtocolsAdult

Stichwörter der Autor:innen

anti‐CTLA‐4anti‐PD‐1lenvatinibmetastatic melanomapembrolizumabpretreated patients

Substanzen

pembrolizumablenvatinibAntibodies, Monoclonal, HumanizedPhenylurea CompoundsQuinolines

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, Third Faculty of Medicine, Charles University, and Královské Vinohrady University Hospital, Prague, Czech Republic.
  • Department of Oncology, Third Faculty of Medicine, Charles University, and Královské Vinohrady University Hospital, Prague, Czech Republic.

ORCID-Profile: Marek Pásek, Emanuel Marques, Jiří Švec, Petr Arenberger, Monika Arenbergerová

Zitieren

APA

Pásek, M., Marques, E., Švec, J., Arenberger, P., & Arenbergerová, M. (2024). Observational study with lenvatinib and pembrolizumab in heavily pretreated patients with metastatic melanoma. International Journal of Dermatology. https://doi.org/10.1111/ijd.17285

Vancouver

Pásek M, Marques E, Švec J, Arenberger P, Arenbergerová M. Observational study with lenvatinib and pembrolizumab in heavily pretreated patients with metastatic melanoma. International Journal of Dermatology. 2024. doi:10.1111/ijd.17285

BibTeX
@article{Psek2024,
  author = {Pásek, Marek and Marques, Emanuel and Švec, Jiří and Arenberger, Petr and Arenbergerová, Monika},
  title = {Observational study with lenvatinib and pembrolizumab in heavily pretreated patients with metastatic melanoma},
  journal = {International Journal of Dermatology},
  year = {2024},
  doi = {10.1111/ijd.17285}
}
Kostenlos starten →